Results 1 to 10 of about 63,390 (243)

Dra. Arianna Becerril García

Prisma Tecnológico, 2021
Doctora en Ciencias de la Computación. Instituto Tecnológico y de Estudios Superiores de Monterrey, Ciudad de México, México. Ingeniera en Computación Universidad Autónoma del Estado de México Toluca, Estado de México, México Profesora-Investigadora ...
Aránzazu Berbey Álvarez
doaj   +4 more sources

A Navigation and Augmented Reality System for Visually Impaired People

Sensors, 2021
In recent years, we have assisted with an impressive advance in augmented reality systems and computer vision algorithms, based on image processing and artificial intelligence.
Alice Lo Valvo, Daniele Croce, Domenico Garlisi, Fabrizio Giuliano, Laura Giarré, Ilenia Tinnirello   +5 more
doaj   +1 more source

A model of non-pharmacological intervention (Agorà model) on behavioural disorders in patients with Alzheimer’s disease

European Psychiatry, 2021
Introduction Cognitive deficits, behavioral disorders, neuropsychiatric symptoms (BNS) are characteristics in Alzheimer’s disease (AD). Morover, elderly patients often take multiple medications for their several chronic health conditions.
G. Conte, I. Sinisi, F. Franza
doaj   +1 more source

Evaluation of Coaguchek®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study

Bleeding, Thrombosis and Vascular Biology, 2022
Direct oral anticoagulants (DOAC) measurement is recommended in specific conditions. A point-of-care testing should be used in emergency to qualitatively rule out relevant DOAC concentrations.
Cristina Legnani, Michela Cini, Sophie Testa, Alberto Tosetto, Claudia Dellanoce, Stefania Bellesso, Giuseppe Carli, Ilaria Nichele, Laura Lissandrini, Serena Zorzi, Emilia Antonucci, Gualtiero Palareti   +11 more
doaj   +1 more source

Guided antiplatelet therapy in patients undergoing percutaneous coronary intervention

Bleeding, Thrombosis and Vascular Biology, 2023
Not ...
Marco Cattaneo
doaj   +1 more source

Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?

Haematologica, 2023
Essential thrombocythemia (ET) is a BCR-ABL1-negative myeloproliferative neoplasm, the most common clinical manifestations of which include arterial and venous thrombosis, bleeding and vasomotor/microvascular disturbances.
Marco Cattaneo
doaj   +1 more source

New perspectives for prevention of the post-thrombotic syndrome

Bleeding, Thrombosis and Vascular Biology, 2022
While on conventional anticoagulation, up to 50% of patients with one or more episodes of proximal deep vein thrombosis (DVT) can develop post-thrombotic (PTS) manifestations.
Paolo Prandoni
doaj   +1 more source

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register

BMJ Open, 2020
Objective The proportion and characteristics of Italian patients affected by venous thromboembolism (VTE) treated with direct oral anticoagulants (DOACs) or vitamin K antagonists (VKAs), and complications occurring during follow-up.Design A prospective ...
Daniela Poli, Emilia Antonucci, Vittorio Pengo, Niccolò Maggini, Sophie Testa, Antonio Insana, Carmelo Paparo, Pasquale Pignatelli, Gualtiero Palareti, Paolo Prandoni, Elvira Grandone, Cristina Legnani, Daniela Mastroiacovo, Alberto Tosetto, Walter Ageno, Rossella Marcucci, Oriana Paoletti, Giovanna Colombo, Benilde Cosmi, Giuliana Guazzaloca, Ludovica Migliaccio, Anna Falanga, Teresa Lerede, Luca Barcella, Gentian Denas, Elisa Bison, Lucia Ruocco, Paolo Chiarugi, Giuliana Martini, Simona Pedrini, Federica Bertola, Lucilla Masciocco, Pasquale Saracino, Angelo Benvenuto, Claudio Vasselli, Marco Marzolo, Antonietta Piana, Francesco Cibecchini, Andrea Toma, Pietro Barbera, Donatella Colaizzo, Domizio Serra, Daniele Pastori, Serena Rupoli, Giuseppe Malcangi, Giovanni Nante, Rosella Sangiorgio   +46 more
doaj   +1 more source

Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score

Bleeding, Thrombosis and Vascular Biology, 2023
Not ...
Paolo Prandoni
doaj   +1 more source

Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results

Bleeding, Thrombosis and Vascular Biology, 2022
Optimal duration of anticoagulation in patients with a first venous thromboembolism (VTE) is still uncertain. Extended anticoagulant treatment beyond the first 3 to 6 months is recommended in patients with unprovoked VTE for their high risk of ...
Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli   +13 more
doaj   +1 more source